AbCellera
the most broadly used covid antibody in the world since being authorized for emergency use by the us in has prevented hospitalizations and death patients treated patients kept out of hospital lives saved recently transitioned to the combination of and in the us | AbCellera
Company
Deck Type
Sector
Industry
Deck date
May 2021
Slide
7 of 15
Related slides by other companies
Fusion Pharmaceuticals
Investor Presentation
January 2024
program milestones patients | Fusion Pharmaceuticals
OmniAb
Investor Presentation
May 2023
active programs by antibody source technology | OmniAb
argenx SE
Results
July 2021
our pipeline starts with our immunology innovation program | argenx SE
OmniAb
Investor Conference
November 2022
antibody repertoire source used | OmniAb
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io